Demystifying Ameren: Insights From 6 Analyst Reviews
Portfolio Pulse from Benzinga Insights
Six analysts have recently reviewed Ameren (NYSE:AEE), with an average 12-month price target of $79.5, down 3.28% from the previous average. Ratings range from neutral to overweight, with price target adjustments reflecting changes in market dynamics and company performance. Ameren's financials show a revenue decline of -10.67% over 3 months, but strong net margin and ROE. The company's market cap is below industry averages, and it has a lower debt-to-equity ratio, indicating conservative financial management.
January 04, 2024 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Analysts have mixed views on Ameren, with a recent average price target decrease to $79.5. The company's financials show a revenue decline but strong net margin and ROE, indicating a solid financial position despite revenue challenges.
The mixed analyst ratings and the slight decrease in the average price target suggest a neutral short-term impact on AEE's stock price. The company's strong net margin and ROE may counterbalance the negative sentiment from the revenue decline, leading to a neutral score. The relevance is 100 as the article is directly about Ameren. The importance is set at 75 due to the combination of analyst ratings and financial performance indicators, which are significant for investors. The confidence level is 90, reflecting the clear data provided in the article.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100